MLH1 Promoter Hypermethylation in Uterine Carcinosarcoma Rarely Coexists With TP53 Mutation

Wspolczesna Onkologia - Poland
doi 10.5114/wo.2019.89635
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Termedia Sp. z.o.o.

Related search

Uterine Carcinosarcoma in a Patient With Didelphys Uterus

Case Reports in Obstetrics and Gynecology
2013English

Role of TGF-β Signaling in Uterine Carcinosarcoma

Oncotarget
Oncology
2015English

MGMT Promoter Hypermethylation and K-Ras, PTEN and TP53 Mutations in Tamoxifen-Exposed and Non-Exposed Endometrial Cancer Cases

British Journal of Cancer
Cancer ResearchOncology
2014English

TGFBI Promoter Hypermethylation Correlating With Paclitaxel Chemoresistance in Ovarian Cancer

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2012English

P30.10: Ultrasound and Clinical Features of Uterine Carcinosarcoma

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2017English

Gene Promoter Hypermethylation in Mouse Lung Tumors

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2006English

The MLH1 −93 Promoter Variant Influences Gene Expression

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2010English

An Intronic Mutation in MLH1 Associated With Familial Colon and Breast Cancer

Familial Cancer
Cancer ResearchOncologyGenetics
2010English

OP08.10: The Ultrasonographic Findings of Uterine Carcinosarcoma

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy